Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Jul 27, 2015
Hovione and Invion sign development agreement for first inhaled non-steroidal anti-inflammatory for asthma
Read more
Scientific Article
/ Nov 03, 2014
Improving the Aerodynamic Performance of Fluticasone Propionate Powders by Tuning Particle Size through Wet Polishing
Read more
Scientific Article
/ Nov 03, 2014
Optimization of a Roller Compaction Process for a Spray Dryer Formulation Using Powder Rheology
Read more
Scientific Article